Sigma-Aldrich Collaborates With CatScI
Sigma-Aldrich Corporation (SIAL) announced that its custom manufacturing services business unit – SAFC Commercial – has entered into a services agreement with CatScI Ltd. With the deal in place, SAFC customers will get access to metal removal, recovery and recycling services along with immediate access to new reactions, homogeneous and heterogeneous catalysis, biocatalysts, solvent selection and process development.
The partnership will leverage CatScI’s expertise in catalyzed reactions and complex chemical processes and SAFC’s process development, scale-up, and manufacturing know-how.
CatScI provides novel solutions and caters to all types of challenging synthetic chemistry problems. The company has a strong technology platform and provides differentiated services in a cost and time efficient manner. CatScI provides expertise in both chemo and bio-catalysis and the customers can take advantage of it for the suggestion, screening, selection, development and optimization of reactions and processes.
Catalysis is gaining importance in the pharmaceutical industry and about 90% of chemicals now require the use of catalytic processes in their manufacture. With chemical processes becoming more and more complex, industrial chemists look forward to employing catalysis to achieve concise and economical processes in R&D and production.
CatScI is a UK-based catalysis company that aims at maximizing yield, optimizing quality, reducing waste and minimizing chemical development costs through reaction understanding. Sigma-Aldrich is a lab chemical and life sciences company focused on enhancing human health and safety.
Sigma-Aldrich currently maintains a Zacks Rank #3 (Hold).
Other companies in the specialty chemical industry worth considering are Ecolab Inc. (ECL), Ferro Corporation (FOE), and HB Fuller Co. (FUL). All of them carry a Zacks Rank #2 (Buy).
Read the Full Research Report on SIAL
Read the Full Research Report on ECL
Read the Full Research Report on FOE
Read the Full Research Report on FUL
Zacks Investment Research
